Literature DB >> 17951666

Generation of osteoclasts in vitro, and assay of osteoclast activity.

Naoyuki Takahashi, Nobuyuki Udagawa, Yasuhiro Kobayashi, Tatsuo Suda.   

Abstract

Osteoclasts are bone-resorbing multinucleated cells derived from the monocyte-macrophage lineage. The authors have developed a mouse marrow culture system and a coculture system of mouse osteoblasts and hemopoietic cells, in which osteoclasts are formed in response to various osteotropic factors such as 1alpha,25-dihydroxyvitamin D3, parathyroid hormone, prostaglandin E2, and interleukin-11. Recent studies have revealed that osteoblasts express two cytokines essential for osteoclastogenesis: receptor activator of nuclear factor kappaB ligand (RANKL) and macrophage colony-stimulating factor (M-CSF). Using RANKL and M-CSF, we can induce osteoclasts from monocyte-macrophage lineage cells even in the absence of osteoblasts. This chapter describes the methods for osteoclast formation in vitro in the presence and absence of osteoblasts, and for pit-formation assay using dentine slices and osteoclasts formed in vitro. These culture systems have made it possible to investigate each step of osteoclast development and function separately.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17951666     DOI: 10.1007/978-1-59745-401-8_18

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  27 in total

1.  N-methyl pyrrolidone (NMP) inhibits lipopolysaccharide-induced inflammation by suppressing NF-κB signaling.

Authors:  Chafik Ghayor; Bebeka Gjoksi; Barbara Siegenthaler; Franz E Weber
Journal:  Inflamm Res       Date:  2015-06-06       Impact factor: 4.575

2.  Soluble RANKL Cleaved from Activated Lymphocytes by TNF-α-Converting Enzyme Contributes to Osteoclastogenesis in Periodontitis.

Authors:  Hiroyuki Kanzaki; Seicho Makihira; Maiko Suzuki; Takenobu Ishii; Alexandru Movila; Josefine Hirschfeld; Hani Mawardi; Xiaoping Lin; Xiaozhe Han; Martin A Taubman; Toshihisa Kawai
Journal:  J Immunol       Date:  2016-10-07       Impact factor: 5.422

3.  The dynamin inhibitor dynasore inhibits bone resorption by rapidly disrupting actin rings of osteoclasts.

Authors:  Gnanasagar J Thirukonda; Shunsuke Uehara; Takahiro Nakayama; Teruhito Yamashita; Yukio Nakamura; Toshihide Mizoguchi; Naoyuki Takahashi; Kimitoshi Yagami; Nobuyuki Udagawa; Yasuhiro Kobayashi
Journal:  J Bone Miner Metab       Date:  2015-06-11       Impact factor: 2.626

4.  The Proteasome Inhibitor Carfilzomib Suppresses Parathyroid Hormone-induced Osteoclastogenesis through a RANKL-mediated Signaling Pathway.

Authors:  Yanmei Yang; Harry C Blair; Irving M Shapiro; Bin Wang
Journal:  J Biol Chem       Date:  2015-05-15       Impact factor: 5.157

5.  Bisphosphonate Withdrawal: Effects on Bone Formation and Bone Resorption in Maturing Male Mice.

Authors:  Frank C Ko; Lamya Karim; Daniel J Brooks; Mary L Bouxsein; Marie B Demay
Journal:  J Bone Miner Res       Date:  2017-01-17       Impact factor: 6.741

6.  Inhibition of osteoclast differentiation and bone resorption by N-methylpyrrolidone.

Authors:  Chafik Ghayor; Rita M Correro; Katrin Lange; Lindsay S Karfeld-Sulzer; Klaus W Grätz; Franz E Weber
Journal:  J Biol Chem       Date:  2011-05-25       Impact factor: 5.157

7.  Vitamin D supplementation protects against bone loss following inhalant organic dust and lipopolysaccharide exposures in mice.

Authors:  Anand Dusad; Geoffrey M Thiele; Lynell W Klassen; Dong Wang; Michael J Duryee; Ted R Mikuls; Elizabeth B Staab; Todd A Wyatt; William W West; Stephen J Reynolds; Debra J Romberger; Jill A Poole
Journal:  Immunol Res       Date:  2015-05       Impact factor: 2.829

8.  Cystathionine γ-lyase accelerates osteoclast differentiation: identification of a novel regulator of osteoclastogenesis by proteomic analysis.

Authors:  Takahiro Itou; Natalia Maldonado; Iwao Yamada; Claudia Goettsch; Jiro Matsumoto; Masanori Aikawa; Sasha Singh; Elena Aikawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-12-19       Impact factor: 8.311

9.  Coptisine inhibits RANKL-induced NF-κB phosphorylation in osteoclast precursors and suppresses function through the regulation of RANKL and OPG gene expression in osteoblastic cells.

Authors:  Ji-Won Lee; Ayumi Iwahashi; Shin-ichi Hasegawa; Takayuki Yonezawa; Won Bae Jeon; Byung-Yoon Cha; Kazuo Nagai; Je-Tae Woo
Journal:  J Nat Med       Date:  2011-06-09       Impact factor: 2.343

10.  Alpha-1 antitrypsin inhibits RANKL-induced osteoclast formation and functions.

Authors:  Mohammad Ahsanul Akbar; David Nardo; Mong-Jen Chen; Ahmed S Elshikha; Rubina Ahamed; Eslam M Elsayed; Claire Bigot; Lexie Shannon Holliday; Sihong Song
Journal:  Mol Med       Date:  2017-03-21       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.